News Merck & Co boosted by Keytruda first-line lung cancer trial KEYNOTE-189 results could see US Merck tighten its grip in cancer immunotherapy.
News AZ's Lynparza becomes first PARP drug approved in breast can... Lynparza first in class approved in breast cancer
News Syndax announces further entinostat collaboration with Roche Syndax Pharmaceuticals has announced a new collaboration with Roche’s Genentech unit dedicated to combining small molecule cancer drug entinostat with the latter’s immunotherapy, Tecentriq.
Events Partner Content 3rd International Conference on Pancreatic Cancer and Liver ... Making Life Better: Fight Against Pancreatic Cancer
News Activist investor renews its criticism of Novavax Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
